Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Splenic Marginal Zone Lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis.
Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis.
Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue.
Effect of integrated Yoga and Physical therapy on audiovisual reaction time, anxiety and depression in patients with chronic multiple sclerosis: a pilot study.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases.
Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran.
The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.
Heat shock protein 70-hom gene polymorphism and protein expression in multiple sclerosis.
Histopathological effects of intramuscular metamizole sodium on rat sciatic nerve.
Gender, ethnicity, and physician-patient communication about depression and anxiety in primary care.
Re: Prevalence of Sexual Dysfunctions among Women with Multiple Sclerosis.
Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
Pages
« first
‹ previous
…
682
683
684
685
686
687
688
689
690
…
next ›
last »